Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1991
09/11/1991EP0445304A1 Isolated, physiologically active human thrombomodulin polypeptide
09/11/1991EP0445228A1 Immunotherapy involving cd28 stimulation
09/11/1991EP0445227A1 Position-specific insertion vectors and method of using same
09/11/1991EP0445218A1 Neural cell transplantation
09/11/1991EP0445178A1 Use of tnf in the treatment of skin diseases
09/11/1991EP0445145A1 Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon
09/11/1991EP0441871A4 A sheet feeding apparatus
09/11/1991EP0188479B1 Lymphokine production and purification
09/10/1991WO1991013984A2 Interleukin-4 binding proteins
09/10/1991WO1991013925A1 Method for polymerization of epoxide compounds
09/10/1991WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt
09/10/1991WO1991013892A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/10/1991WO1991013870A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991US5048044 Optically pumped lasers
09/10/1991US5047507 Diagnosis And Therapy Of Cancer
09/10/1991US5047506 Method for the purification of factor XIII by affinity chromatography
09/10/1991US5047503 Prepared by ion exchange and affinity chromatography from human urine; remedy for thrombosis
09/10/1991US5047502 Cell Growth Inhibitors
09/10/1991US5047401 Use of dipeptide alkyl esters to treat GVHD
09/10/1991US5047400 Treatment of infection; antitumor agents
09/10/1991US5047398 1-Deamino-8-Arginine Vasopressin
09/10/1991US5047397 Linear analogs of atrial natriuretic peptides
09/10/1991US5047396 Intravenous pharmaceutical composition and process for preparing the same
09/10/1991US5047395 Reduction of oxyradical damage in biomedical applications
09/10/1991US5047336 DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
09/10/1991US5047333 Method for the preparation of natural human growth hormone in pure form
09/10/1991US5047249 Compositions and methods for treating skin conditions and promoting wound healing
09/10/1991US5047241 Anticoagulants
09/10/1991US5047236 Method of treating stroke
09/10/1991CA2077746A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991CA2077645A1 Organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/10/1991CA2076030A1 Interleukin-4 binding proteins
09/10/1991CA2037835A1 Tri-functional antibody-like compounds as a combined diagnostic and therapeutics agent
09/10/1991CA2037811A1 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
09/10/1991CA2037153A1 Acetic acid derivatives
09/10/1991CA1288895C Inducer factor of t-suppressor cells
09/10/1991CA1288894C Physiologically active peptides having bronchodilative and hypotensive activity
09/10/1991CA1288893C Antihypertensive derivatives
09/10/1991CA1288711C Therapeutic blood product means and methods of preparing same
09/10/1991CA1288695C Method for increasing bone mass
09/10/1991CA1288694C Process for treatment of diseases
09/10/1991CA1288688C Method for the diagnosis and treatment of inflammation
09/09/1991CA2037738A1 Active ingredient coating process using a ph-sensitive polymer
09/08/1991WO1991013907A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them
09/08/1991WO1991013874A1 Derivatives of glycinamide, their preparation and medicaments containing them
09/08/1991CA2074375A1 N-phenyl glycinamide derivatives, preparation thereof and drugs containing same
09/08/1991CA2074357A1 Glucinamid derivatives, their preparation and drugs containing them
09/07/1991CA2037531A1 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it
09/07/1991CA2037499A1 Preparation of a thrombin-binding substance
09/06/1991WO1991013904A1 Chymotrypsin-like proteases and their inhibitors
09/06/1991CA2077665A1 Chymotrypsin-like proteases and their inhibitors
09/06/1991CA2037478A1 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
09/06/1991CA2037238A1 Method for treating pneumocystis pneumonia
09/05/1991WO1991013167A1 Identification and expression of insect steroid receptor dna sequences
09/05/1991WO1991013158A1 Protein production in yeast
09/05/1991WO1991013149A1 Tissue plaminogen activator having fibrin specific properties
09/05/1991WO1991013148A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
09/05/1991WO1991013094A1 Inhibitor of proliferation of endothelial cells
09/05/1991WO1991013092A1 Vasoactive vasotocin derivatives
09/05/1991WO1991013086A1 Endotoxin-induced thrombosis factor which induces procoagulant activity in epithelial cells
09/05/1991WO1991013077A1 Calcium channel compositions and methods
09/05/1991WO1991012849A1 Engrafting allogeneic tissues or organs using interleukin
09/05/1991WO1991012818A1 Superantigen induced immune non-responsiveness
09/05/1991WO1991012816A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
09/05/1991WO1991012814A1 Activation of monocyte/macrophages
09/05/1991WO1991012812A1 Inhibitors of catalytic antibodies
09/05/1991WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses
09/05/1991WO1991012808A1 Artificial tears
09/05/1991WO1991010722A3 Chimeric immunoglobulin for cd4 receptors
09/05/1991WO1991006866A3 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
09/05/1991WO1991006314A3 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
09/05/1991DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours
09/05/1991CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses
09/04/1991EP0445078A1 New use of a monoclonal antibody
09/04/1991EP0444961A1 Her3: A novel EGF receptor homolog
09/04/1991EP0444897A1 Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
09/04/1991EP0444692A1 Thrombin composition for oral administration
09/04/1991EP0444691A1 Use of interleukin-1 to enhance the immune response of weakly immunogenic tumors
09/04/1991EP0444638A2 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
09/04/1991EP0444605A2 Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof
09/04/1991EP0444560A1 Antibody specific for the tumor necrosis factor receptor
09/04/1991EP0444181A1 C-erbb-2 external domain: gp75
09/04/1991EP0444157A1 Collagen-polymer conjugates
09/04/1991EP0444156A1 Method for treating vascular diseases
09/04/1991EP0444149A1 High molecular weight human angiogenic factors
09/04/1991EP0444129A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
09/04/1991EP0444081A1 Pharmaceutical preparation
09/04/1991EP0271542B1 An acellular red blood cell substitute
09/04/1991CA2037446A1 Human monoclonal antibodies against rabies viruses, the production and the use thereof
09/03/1991WO1991013173A1 PTPase DIAGNOSTICS AND USES THEREOF
09/03/1991WO1991013166A1 Antibody constructs with enhanced binding affinity
09/03/1991WO1991013093A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME
09/03/1991WO1991013090A1 Improved chimeric toxins
09/03/1991WO1991013087A1 Hybrid compound purification
09/03/1991WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
09/03/1991US5045633 Expression of biologically active PDGF analogs in eucaryotic cells
09/03/1991US5045631 Polypeptides with cell-spreading activity
09/03/1991US5045537 Hydrophilic renin inhibitors, their preparation and use
09/03/1991US5045531 Administering amphiphilic polypeptide as wound healing agent
09/03/1991US5045471 Cloned DNA for P450scc and expression thereof
1 ... 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 ... 3163